Usefulness of mbds in detection of adverse drug events;Utilidad del CMBD para la detección de acontecimientos adversos por medicamentos

Anales de Medicina Interna

Volumn 24, Issue 3, 2007, Pages 113-119

  Sánchez Muñoz, Luis Ángel ^a   Castiella Herrero, J ^a   Sanjuan Portugal F J ^a   Naya Manchado, J ^a   Alfaro Alfaro, M J ^a  

^a Fundacion Hospital Calahorra   (Spain)

Author keywords

Adverse drug events; Drug therapy adverse effects; Drug related adverse reactions; Medication errors; Preventability

Indexed keywords

AMIODARONE; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIINFECTIVE AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CORTICOSTEROID; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOCORTICOID; HEPARIN; INSULIN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; ORAL ANTIDIABETIC AGENT;

ABDOMINAL PAIN; ADULT; ADVERSE DRUG REACTION; AGED; ANAPHYLACTIC SHOCK; ANEMIA; ANGIONEUROTIC EDEMA; ARTICLE; BLEEDING; BRADYCARDIA; BRONCHOSPASM; CANDIDIASIS; CLINICAL FEATURE; CONFUSION; CONVULSION; DIARRHEA; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EMERGENCY WARD; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMATOMA; HEMOPTYSIS; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; HYPERKALEMIA; HYPERTHYROIDISM; HYPOGLYCEMIA; HYPOKALEMIA; HYPONATREMIA; HYPOTENSION; INCIDENCE; INFORMATION PROCESSING; KIDNEY FAILURE; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; METABOLIC ACIDOSIS; NAUSEA; NEUTROPENIA; PARALYTIC ILEUS; PUBLIC HOSPITAL; PURPURA; RASH; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SOMNOLENCE; STOMACH ULCER; SYNCOPE; THRUSH; TIME SERIES ANALYSIS; URTICARIA; VOMITING; MIDDLE AGED; SPAIN;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SPAIN;

EID: 34548039443     PISSN: 02127199     EISSN: 02127199     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Otero MJ, Domínguez A. Acontecimientos adversos por medicamentos: una patología emergente. Farm Hosp 2000; 24: 258-66.
2. Kohn LT, Corrigan JM, Donaldson MS, eds. To err is human: Building a safer health system. Committee on Health Care in America. Institute of Medicine. Washington (DC): National Academy Press, 1999.
3. Expert Group on Learning from Adverse Events in the NHS. An organisation with a memory: report of an expert group on learning from adverse events in the NHS. London: Stationery Office, 2000. (Accedido 20 septiembre 2006). Disponible en: www.doh.gov.uk/pdfs/org.pdf
4. Department of Health. Building a safer NHS for patients, 2001 (Accedido 20 septiembre 2006). Disponible en: http://www.dh.gov.uk/assetRoot/04/05/80/94/ 04058094.pdf. 2001.
5. National Patient Safety Agency. Seven steps to patient safety. 2004. (Accedido 20 septiembre 2006). Disponible en: http://www.npsa.nhs.uk/health/ resources/7steps
6. American Hospital Association, Health Research & Educational Trust, and the Institute for Safe Medication Practices. Pathways for Medication Safety.2002. (Accedido 20 septiembre 2006). Disponible en: http://www.ismp.org/ Tools/PathwaySection1.pdf, http://www.ismp.org/Tools/PathwaySection2.pdf, http://www.ismp.org/Tools/Pathway-Section3.pdf.
7. World Health Organization. World Alliance fo Patient Safety. Forward Programme 2005 (Accedido 20 septiembre 2006). Disponible en: http://www.who.int/patientsafety/en/brochure_final.pdf
8. Plan de Calidad para el Sistema Nacional de Salud. Marzo-06, Secretaría General de Sanidad. Agencia de Calidad del SNS. (Accedido 20 septiembre 2006). Disponible en: http://www.msc.es/novedades/docs/ notaPrensa20060323TextoIntegro.pdf
9. Nelson KM, Talbert RL. Drug-related hospital admissions. Pharmacotherapy 1996;16:701-7.
10. Hallas J, Harvald B, Gram LF, Grodum E, Brosen K, Haghfelt T, et al. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med 1990; 228: 83-90.
11. Hallas J, Gram LF, Grodum E, Damsbo N, Brosen K, Haghfelt T, et al. Drug related admissions to medical wards: a population based survey. Br J Clin Pharmac 1992; 33: 61-8.
12. Dartnell JGA, Anderson RP, Chohan V, Galbraith KJ, Lyon MEH, Nestor PJ, et al. Hospitalisation for adverse events related to drug therapy: incidence, avoidability and costs. Med J Aust 1996; 164: 659-62.
13. Stanton LA, Peterson GM, Rumble RH, Cooper GM, Polack AE. Drug related admissions to an Australian hospital. J Clin Pharm Ther 1994; 19: 341-7.
14. Armadans L, Carné X, Laporte JR. Detección de reacciones adversas a medicamentos a partir del diagnóstico de ingreso hospitalario. Métodos y resultados. Med Clin (Barc) 1998; 91: 124-7.
15. Garijo B, De Abajo FJ, Castro MAS, Lopo CR, Carcas A, Frías J. Hospitalizaciones motivadas por fármacos: un estudio prospectivo. Rev Clin Esp 1991; 188: 7-12.
16. Ibáñez L, Laporte JR, Carné X. Adverse drug reactions leading to hospital admission. Drug Safety 1991; 6: 450-59.
17. Martín MT, Codina C, Tuset M, Carné X, Nogué S, Ribas J. Problemas relacionados con la medicación como causa del ingreso hospitalario. Med Clin (Barc) 2002; 118 (6): 205-10
18. Lazarou J, Pomeranz B, Corey P. Incidente of adverse drug reaction in hospitalizad patines. A metaanalisis of prospective studies. JAMA 1998; 279: 1200-5.
19. Baker GR, Norton PG, Flintoft V, Blais R, Brown A, Cox J, et al. The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada. CMAJ 2004; 170 (11): 1678-86
20. Cullen DJ, Sweitzer BJ, Bates DW, Burdick E, Edmondson A, Leape LL. Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. Crit Care Med 1997; 25: 1289-97.
21. Nelson K, Talbert R. Drug related hospital admissions. Pharmacotherapy 1996; 16: 701-7.
22. Muñoz MJ, Ayani I, Rodríguez Sasiáin JM, Gutiérrez G, Aguirre C. Monitorización en un servicio de urgencias de reacciones adversas causadas por medicamentos en niños y adultos. Med Clin (Barc) 1998; 114: 92-8.
23. Forster AJ, Clark HD, Menard A, Dupuis N, Chernish R, Chandok N, et al. Adverse events among medical patients after discharge from hospital.. CMAJ 2004; 170 (3): 345-9
24. Estudio Nacional sobre los Efectos Adversos ligados a la Hospitalización. ENEAS 2005. Informe Febrero 2006. Secretaría General de Sanidad. Dirección General de la Agencia de Calidad del Sistema Nacional de Salud. Ministerio de Sanidad y Consumo. Accesible en http: //www.msc.es/organizacion/sns/planCalidadSNS/docs/eneas2005Baja.pdf#search= %22ENEAS%20filetype%3Apdf%22
25. World Health Organization. Requirements for adverse reaction reporting. Geneva, Switzerland: World Health Organization, 1975.
26. Otero MJ, Codina C, Tamés MJ, Pérez M, et al. Errores de medicación: estandarización de la terminología y clasificación. Resultados de la Beca Ruiz-Jarabo 2000. Farm Hosp 2003; 27 (3): 137-149
27. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. Incidence of adverse drug events and potencial adverse drug events. JAMA 1995; 274: 29-34.
28. Dennehy CE, Kishi DT, Louie C. Drug-related illness in emergency department patients. Am J Health-Syst Pharm 1996; 53: 1422-6.
29. Pearson TF, Pittman DG, Longley JM, Grapes T, Vigliotti DJ, Mullis SR. Factors associated with preventable adverse drug reactions. Am J Health- Syst Pharm 1994; 51: 2268-72.
30. Goettler M, Schneewiss S, Hasford J. Adverse drug reactions monitoring -cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission. Pharmacoepidemiol Drug Safety 1997; 6(Suppl 3): 79-90.
31. Seeger JD, Kong SX, Schumock GT. Characteristics associated with ability to prevent adverse drug reactions in hospitalized patients. Pharmacotherapy 1998; 18: 1284-9.
32. Otero MJ, Bajo A, Maderuelo JA, Domínguez-Gil A. Evitabilidad de los acontecimientos adversos inducidos por medicamentos detectados en un Servicio de Urgencias. Rev Clin Esp 1999; 199: 796-805.
33. Tafreshi MJ, Melby MJ, Kaback KR, Nord TC. Medication-related visits to the emergency department: a prospective study. Ann Pharmacother 1999; 33: 1252-7.
34. related emergency department visits and hospital admissions. Am J Hosp Pharm 1992; 49: 1696-700.
35. WHO. Collaborating Centre for International Drug Monitoring. International monitoring of adverse drug reactions. Ginebra, 1988.
36. Consejo General de Colegios Oficiales de Farmacéuticos. Catálogos de especialidades Farmacéuticas. Madrid, 1995.
37. Schumock GT, Thorton JP. Focusing on preventability of adverse drug reactions. Hosp Pharm 1992; 27: 538.
38. Anónimo. Centros Autónomos de Farmacovigilancia: Ministerio de Sanidad y Consumo, 1994.
39. Aguirre C. Utilización del CMBD hospitalario como fuente de información en farmacovigilancia. Libro resúmenes de las III Jornadas de Farmacovigilancia. Pág.30-35. (Accedido 20 septiembre 2006). Disponible en: http: //www.jccm.es/sanidad/reuniones/farmacovigilancia/libro.pdf
40. Rubio A, Perea S. Evaluación de reacciones adversas a medicamentos en un hospital general. Libro resúmenes de las III Jornadas de Farmacovigilancia. Pág.86. (Accedido 20 septiembre 2006). Disponible en: http: //www.jccm.es/sanidad/reuniones/farmacovigilancia/libro.pdf
41. Torelló J, Castillo JR, Mengíbar A, Vigil E. Análisis de las RAM registradas en el CMBD de los hospitales universitarios Virgen del Rocío (HHUUVR). Libro resúmenes de las III Jornadas de Farmacovigilancia. Pág.84. (Accedido 20 septiembre 2006). Disponible en: http: //www.jccm.es/sanidad/reuniones/farmacovigilancia/libro. pdf
42. Cullen DJ, Sweitzer BJ, Bates DW, Burdick E, Edmondson A, Leape LL. Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. Crit Care Med 1997; 25: 1289-97.
43. Navarro-Calderón E, Navarro MJ, Muelas J, Escoms V, Rodríguez R, Salazar A. Importancia de la búsqueda activa en la detección de reacciones adversas medicamentosas. Seguim Farmacoter 2004; 2(1): 24-28.
44. Navarro-Calderón E, Navarro MJ, Muelas J, Salazar A. Exhaustividad de la declaración de reacciones adversas medicamentosas. Seguim Farmacoter 2004; 2(4): 244-249.
45. Navarro-Calderón E, Navarro MJ, Muelas J, Escoms V, Salazar A. Utilidad del CMBD en la declaración de efectos adversos medicamentosos. Boletin epidemiológico semanal.Centro Nacional de Epidemiología. Semanas: 43-44 del 19/10 al 01/11 de 2003. 2003 vol. 11 no 23/265-276.
46. Corral S, Guerrero MD; Beltrán M, Salas J. Utilización del CMBD como herramienta para la detección de acontecimientos adversos a medicamentos. Farm Hosp (Madrid) 2004; 28 (4): 258-265
47. Otero MJ, Alonso P, Maderuelo JA, Garrido B, Domínguez A, Sánchez A. Acontecimientos adversos prevenibles causados por medicamentos en pacientes hospitalizados. Med Clin (Barc) 2006; 126 (3): 81-7.
48. Manesse C, Derkx FH, Ridder MA, Veld AJ, Van der Cammen TJ. Contribution of adverse drug reactions to hospital admisión of older patients. Age and Ageing 2000; 29: 35-39.
49. Sanchez M, Delgado L, Delgado E, Prieto S, Bermejo T. Detección y análisis de reacciones adversas a medicamentos en el servicio de Urgencias de un hospital general. Farm Hosp. 2006; 30 (2): 78-84.
50. Walker J, Wynne H. Review: The frequency and severity of adevrse drug reactions in elderly people. Age Aging. 1994; 23: 255-9
51. Roughead E, Gilbert A, Primrose J, Sansom L. Drug-related hospital admissions: a review of Australian studies published 1988-1996. Med J Aust 1998; 168: 405-8.
52. Vilà A, San José A, Roure C, Armadans L, Vilardell M, y Grupo para el estudio de las Reacciones Adversas a Medicamentos en pacientes mayores hospitalizados. Estudio multicéntrico prospectivo de reacciones adversas a medicamentos en pacientes ancianos hospitalizados. Med Clin (Barc) 2003; 120(16): 613-8
53. Thomas EJ, Brennan TA . Incidence and types of preventable adverse events in elderly patients: population based review of medical records. BMJ 2000; 320: 741-744.
54. Gurwitz JH, Field TS, Avorn J, McCormick D, Jain S, Benser M, et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000; 109: 87-94.
55. Seidl LG, Thornton GF, Smith JW, Cluff LE. Studies on the epidemiology of adverse drug reactions: reactions in patients in a general medical service. Bull John Hopkins Hosp 1966; 119: 299-315.
56. Carbonin P. Is age an independent risk factor of ADRs in hospitalised medical patients J Am Geriatr Soc 19991; 39: 1093-9.
57. Ajayi FO, Perry J. Adverse drug reaction: a review of relevant factors. J Clin Pharmacol 2000; 40: 1090-1101.
58. Puche E, Luna J. Reacciones adversas a medicamentos: una revisión actualizada del problema en España. Rev Clin Esp 2006; 206 (7): 336-9.
59. Oren E, Shaffer ER, Guglielmo BJ. Impact Of Emerging Technologies On Medication Errors And Adverse Drug Events. Am J Health-Syst Pharm 2003; 60: 1447-58
60. Kuperman GJ, Gibson RF. Computer Physician Order Entry: Benefits, Costs, And Issues. Ann Intern Med 2003; 139: 31-39.
61. Kaushal R, Shojania Kg, Bates Dw. Efects Of Computer Physician Order Entry And Clinical Decision Support Systems On Medication Safety. A Systematic Review. Arch Intern Med 2003; 163: 1409-16.